Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
178
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Day One Biopharmaceuticals Inc market cap is $2.22B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Day One Biopharmaceuticals Inc 52 week high is $21.53 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Day One Biopharmaceuticals Inc 52 week low is $5.64 as of November 22, 2026.
Day One Biopharmaceuticals Inc stock price today is $21.53.
Day One Biopharmaceuticals Inc stock price yesterday was $21.49.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Day One Biopharmaceuticals Inc's P/E ratio is -20.66.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Day One Biopharmaceuticals Inc P/B ratio is 5.0259.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Day One Biopharmaceuticals Inc 50-day moving average is $19.41.